573 related articles for article (PubMed ID: 19324877)
1. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition.
Zhang H; Liu CY; Zha ZY; Zhao B; Yao J; Zhao S; Xiong Y; Lei QY; Guan KL
J Biol Chem; 2009 May; 284(20):13355-13362. PubMed ID: 19324877
[TBL] [Abstract][Full Text] [Related]
2. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
[TBL] [Abstract][Full Text] [Related]
3. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
4. Effects of TAZ on human dental pulp stem cell proliferation and migration.
Tian S; Tian X; Liu Y; Dong F; Wang J; Liu X; Zhang Z; Chen H
Mol Med Rep; 2017 Jun; 15(6):4326-4332. PubMed ID: 28487958
[TBL] [Abstract][Full Text] [Related]
5. Truncated TEAD-binding protein of TAZ inhibits glioma survival through the induction of apoptosis and repression of epithelial-mesenchymal transition.
Zhao W; Li LW; Tian RF; Dong QF; Li PQ; Yan ZF; Yang X; Huo JL; Fei Z; Zhen HN
J Cell Biochem; 2019 Oct; 120(10):17337-17344. PubMed ID: 31209945
[TBL] [Abstract][Full Text] [Related]
6. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
[TBL] [Abstract][Full Text] [Related]
7. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.
Rashidian J; Le Scolan E; Ji X; Zhu Q; Mulvihill MM; Nomura D; Luo K
Sci Signal; 2015 Feb; 8(363):ra14. PubMed ID: 25670202
[TBL] [Abstract][Full Text] [Related]
8. Convergence of YAP/TAZ, TEAD and TP63 activity is associated with bronchial premalignant severity and progression.
Ning B; Tilston-Lunel AM; Simonetti J; Hicks-Berthet J; Matschulat A; Pfefferkorn R; Spira A; Edwards M; Mazzilli S; Lenburg ME; Beane JE; Varelas X
J Exp Clin Cancer Res; 2023 May; 42(1):116. PubMed ID: 37150829
[TBL] [Abstract][Full Text] [Related]
9. TAZ promotes epithelial to mesenchymal transition via the upregulation of connective tissue growth factor expression in neuroblastoma cells.
Wang Q; Xu Z; An Q; Jiang D; Wang L; Liang B; Li Z
Mol Med Rep; 2015 Feb; 11(2):982-8. PubMed ID: 25354978
[TBL] [Abstract][Full Text] [Related]
10. Validation of chemical compound library screening for transcriptional co-activator with PDZ-binding motif inhibitors using GFP-fused transcriptional co-activator with PDZ-binding motif.
Nagashima S; Maruyama J; Kawano S; Iwasa H; Nakagawa K; Ishigami-Yuasa M; Kagechika H; Nishina H; Hata Y
Cancer Sci; 2016 Jun; 107(6):791-802. PubMed ID: 27009852
[TBL] [Abstract][Full Text] [Related]
11. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
Liu CY; Yu T; Huang Y; Cui L; Hong W
J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of Hippo-TAZ pathway during renal injury confers a fibrotic maladaptive phenotype.
Anorga S; Overstreet JM; Falke LL; Tang J; Goldschmeding RG; Higgins PJ; Samarakoon R
FASEB J; 2018 May; 32(5):2644-2657. PubMed ID: 29298862
[TBL] [Abstract][Full Text] [Related]
13. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
[TBL] [Abstract][Full Text] [Related]
14. BMP4 is a novel transcriptional target and mediator of mammary cell migration downstream of the Hippo pathway component TAZ.
Lai D; Yang X
Cell Signal; 2013 Aug; 25(8):1720-8. PubMed ID: 23673366
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
[TBL] [Abstract][Full Text] [Related]
16. Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF.
Lai D; Ho KC; Hao Y; Yang X
Cancer Res; 2011 Apr; 71(7):2728-38. PubMed ID: 21349946
[TBL] [Abstract][Full Text] [Related]
17. Roles of RUNX in Hippo Pathway Signaling.
Passaniti A; Brusgard JL; Qiao Y; Sudol M; Finch-Edmondson M
Adv Exp Med Biol; 2017; 962():435-448. PubMed ID: 28299672
[TBL] [Abstract][Full Text] [Related]
18. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL
Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050
[TBL] [Abstract][Full Text] [Related]
19. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.
Lei QY; Zhang H; Zhao B; Zha ZY; Bai F; Pei XH; Zhao S; Xiong Y; Guan KL
Mol Cell Biol; 2008 Apr; 28(7):2426-36. PubMed ID: 18227151
[TBL] [Abstract][Full Text] [Related]
20. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review.
Crawford JJ; Bronner SM; Zbieg JR
Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112
[No Abstract] [Full Text] [Related]
[Next] [New Search]
